Replies to post #1426 on Avid Bioservices Inc (CDMO)

[DewDiligence]

>>PFE paid half a billion for a drug not even in clinical trials.<<

The deal is heavily back-loaded with only a small fraction of the total amount guaranteed.

>>PFE is clearly establishing itself as a leader in treating eye disorders.<<

In terms of sales, PFE has been #1 or #2 in ophthalmology ever since it acquired Pharmacia (and the blockbuster Xalatan) there years ago. Regards, Dew